Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial

Table 4 Completion rates of measures amongst participants in the observation and pilot randomised controlled trial phase

Completion	Observational phase (n = 20)		Pilot RCT Phase (n = 30)
	Observational phase (n = 20)		Feedback (n = 14)		No feedback (n = 16)
	Full (100%)	Completion range	Full (100%)	Completion range	Full (100%)	Completion range
Performance-based outcomes (n = 5)*
Baseline	n = 3	n = 2 65–75%	n = 2	n = 3 57–78%	n = 0	n = 5 75–93%
3 weeks	n = 0	n = 5 55–70%	n = 0	n = 5 50–85%	n = 0	n = 5 62–75%
12 weeks
Self-report outcomes (n = 5)^{^}
Baseline	n = 2	n = 3 90–95%	n = 2	n = 3 85–92%	n = 0	n = 5 87–93%
3 weeks	n = 0	n = 5 65–70%	n = 0	n = 5 78–85%	n = 0	n = 5 75%
12 weeks (n = 3)	n = 0	n = 3 35–45%	n = 0	n = 3 42–50%	n = 0	n = 3 50%
Smartwatch activity data
Patient data recorded by watch and downloaded by ward staff	n = 20	100%	n = 14	100%	n = 16	100%
Smartwatch data recorded in log	n = 4	20%	n = 14	100%	n = 16	100%

Completion range refers to the percentage of recruited patients whom successfully completed assessment across measures
*Grip strength left, grip strength right, 10-m walk test; MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index
^FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item)

ISSN: 2055-5784